SEVERE APLASTIC ANEMIA
Clinical trials for SEVERE APLASTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new SEVERE APLASTIC ANEMIA trials appear
Sign up with your email to follow new studies for SEVERE APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial aims to find best first treatment for rare blood disorder in kids
⭐️ CURE ⭐️ OngoingThis study compares two standard treatments—bone marrow transplant from an unrelated donor and immune suppressive therapy—as first-line therapy for children and young adults with severe aplastic anemia, a rare condition where the body stops making enough blood cells. About 53 par…
Matched conditions: SEVERE APLASTIC ANEMIA
Phase: PHASE3 • Sponsor: Boston Children's Hospital • Aim: ⭐️ CURE ⭐️
Last updated May 17, 2026 04:28 UTC
-
New drug may keep aplastic anemia at bay after standard treatment ends
Disease control OngoingThis study tests whether the drug sirolimus can prevent severe aplastic anemia from coming back after patients stop taking cyclosporine. About 84 people aged 2 and older who have responded to initial treatment will take sirolimus for 3 months or be monitored without it. The goal …
Matched conditions: SEVERE APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated May 17, 2026 04:28 UTC
-
Could lab-grown stem cells boost bone marrow transplant success?
Disease control ENROLLING_BY_INVITATIONThis early-stage trial tests whether adding specially grown umbilical cord stem cells to a half-matched bone marrow transplant can improve outcomes for people with severe aplastic anemia, a rare condition where the bone marrow stops making enough blood cells. About 40 participant…
Matched conditions: SEVERE APLASTIC ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New transplant technique aims to cut deadly side effects in half-matched donor patients
Disease control OngoingThis study tests a new way to do stem cell transplants using cells from a half-matched family donor. By removing certain immune cells before transplant, researchers hope to lower the risk of graft-versus-host disease, a serious complication. The goal is to help patients with bloo…
Matched conditions: SEVERE APLASTIC ANEMIA
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New drug cocktail aims to tame deadly transplant complication in blood cancer patients
Disease control OngoingThis study tests whether adding a drug called cyclophosphamide after a stem cell transplant can lower the risk of graft-versus-host disease (GVHD), a serious complication where donor cells attack the patient's body. The trial includes 35 adults with various blood cancers or sever…
Matched conditions: SEVERE APLASTIC ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 05, 2026 11:54 UTC
-
New drug combo shows promise for rare blood disorder
Disease control OngoingThis study tests whether adding eltrombopag to standard immune-suppressing drugs can help people with severe aplastic anemia, a rare condition where the immune system attacks the bone marrow. About 207 untreated patients aged 2 and older will receive the combination and be monito…
Matched conditions: SEVERE APLASTIC ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated May 04, 2026 16:23 UTC